• Explore /
  • Poster
  • / Clinical and translational results from REVOLUTION cohorts A (nivolumab + ipilimumab + chemotherapy) and B (hydroxychloroquine + ipilimumab + chemotherapy) in patients with previously untreated metastatic pancreatic adenocarcinoma.

Clinical and translational results from REVOLUTION cohorts A (nivolumab + ipilimumab + chemotherapy) and B (hydroxychloroquine + ipilimumab + chemotherapy) in patients with previously untreated metastatic pancreatic adenocarcinoma.

Abstract Poster

Authors

Eileen M. O'Reilly

Eileen M. O'Reilly

Memorial Sloan Kettering Cancer Center, New York, NY

Eileen M. O'Reilly , Zev A. Wainberg , George A. Fisher Jr., Robert A. Wolff , Andrew H. Ko , Mark H. O'Hara , Christine N Spencer , Jia Xin Yu , Diane M. Da Silva , Lacey J. Padron , Jaclyn P. Lyman , Jonni S. Moore , Brandon Peng , William Hoos , Jill O'Donnell-Tormey , Silvia Boffo , Ute Dugan , Christopher R Cabanski , Ravi K. Amaravadi , Robert H. Vonderheide

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT04787991

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 4137)

DOI

10.1200/JCO.2024.42.16_suppl.4137

Abstract #

4137

Poster Bd #

117

Abstract Disclosures

Similar Posters

First Author: Nong Xu

First Author: Gregory J. Riely

First Author: Michael J. Overman

First Author: Michael J. Overman